Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of alcohol-free Listerine with green tea versus chlorhexidine mouth rinse
ACTRN12619000359134Phase 4Completed
- Sponsor
- Hani Mawardi
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of chlorhexidine in gingival disease (2 arms), sponsored by Hani Mawardi. Primary endpoint: Subjective tolerability composite. Started Apr 2019; status: completed.
02
Drugs
chlorhexidine
03
Conditions
gingival disease
Beyond the preview
Go deeper on ACTRN12619000359134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000359134.